Gian Franco Gensini , Camilla Alderighi , Raffaele Rasoini , Marco Mazzanti , Giancarlo Casolo , Digital SIT (Italian Telemedicine Society), Fiorentino Institute of Care and Assistance (IFCA), Florence, Italy, Fiorentino Institute of Care and Assistance (IFCA), Florence, Italy, International Research Framework on Artificial Intelligence in Cardiology, Royal Brompton Hospital and Harefield NHS Foundation Trust, London, UK, Cardiology Unit, New Versilia Hospital, Lido di Camaiore (LU), Italy
The use of telemonitoring and telemedicine is a relatively new but quickly developing area in medicine. As new digital tools and applications are being created and used to manage medical conditions such as heart failure, many implications require close consideration and further study, including the effectiveness and safety of these telemonitoring tools in diagnosing, treating and managing heart failure compared to traditional face-to-face doctor–patient interaction. When compared to multidisciplinary intervention programs which are frequently hindered by economic, geographic and bureaucratic barriers, non-invasive remote monitoring could be a solution to support and promote the care of patients over time. Therefore it is crucial to identify the most relevant biological parameters to monitor, which heart failure sub-populations may gain real benefits from telehealth interventions and in which specific healthcare subsets these interventions should be implemented in order to maximise value.